Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the 7th Annual Evercore HealthCONx Conference. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Vice-President of Investor Relations Todd Tushla will present at the conference at 10:50 a.m. Eastern Time on Tuesday December 3, 2024 in Coral Gables, Florida.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at Citi's 2024 Healthcare Conference. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Vice-President of Investor Relations Todd Tushla will present at the conference at 1:45 p.m. Eastern Time on Wednesday December 4, 2024 in Miami.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Jefferies London Healthcare Conference. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Chief Medical Officer Eiry Roberts will present at the conference at 1:30 p.m. Greenwich Mean Time (8:30 a.m. Eastern Time) on Tuesday November 19, 2024 in London, United Kingdom.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2024 Healthcare Conference. Chief Financial Officer Matt Abernethy and Chief Commercial Officer Eric Benevich will present at the conference at 10:55 a.m. Eastern Time on Monday November 18, 2024 in New York.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the 2024 UBS Global Healthcare Conference. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Vice-President of Investor Relations Todd Tushla will present at the conference at 1:15 p.m. Pacific Time (4:15 p.m. Eastern Time) on Tuesday November 12, 2024 in Rancho Palos Verdes, CA.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) has scheduled its third quarter 2024 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on October 30, 2024. Earnings presentation link below.
To stay up to date on Neurocrine Biosciences, please sign up for our email alerts.
